Found: 15
Select item for more details and to access through your institution.
Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 9, p. 855, doi. 10.1111/j.1463-1326.2009.01061.x
- By:
- Publication type:
- Article
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 1, p. 32, doi. 10.1111/dme.12799
- By:
- Publication type:
- Article
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 1, p. 46, doi. 10.1111/j.1464-5491.2012.03750.x
- By:
- Publication type:
- Article
Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program.
- Published in:
- Diabetic Medicine, 2012, v. 29, n. 12, p. 1579, doi. 10.1111/j.1464-5491.2012.03662.x
- By:
- Publication type:
- Article
Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2011, v. 28, n. 9, p. 1088, doi. 10.1111/j.1464-5491.2011.03324.x
- By:
- Publication type:
- Article
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 4, p. 326, doi. 10.1111/dom.12220
- By:
- Publication type:
- Article
Metabolic control in diabetic patients. Effect of insulin-secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodies.
- Published in:
- 1979
- By:
- Publication type:
- journal article
An electronic case manager for diabetes control.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study.
- Published in:
- 1997
- By:
- Publication type:
- journal article
A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women.
- Published in:
- International Journal of Obesity & Related Metabolic Disorders, 2003, v. 27, n. 1, p. 82, doi. 10.1038/sj.ijo.0802192
- By:
- Publication type:
- Article
Lipid disorders in diabetes.
- Published in:
- 1981
- By:
- Publication type:
- journal article